{"commentary":{"count":15,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":7,"youtube":4,"podcast":4},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT00565708\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"ASCOLT","nct_id":"NCT00565708","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=ascolt-nct00565708. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"ASCOLT","arms":[{"description":"200mg OD for 3 years","label":"acetylsalicylic acid","type":"EXPERIMENTAL"},{"description":"200mg OD for 3 years","label":"Placebo","type":"PLACEBO_COMPARATOR"}],"collaborators":["Australasian Gastro-Intestinal Trials Group","INDOX Cancer Research Network","University of Sydney"],"completion_date":{"date":"2024-06","type":"ESTIMATED"},"conditions":["Colorectal Cancer"],"enrollment":{"count":1587,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"placebo","type":"OTHER"},{"name":"Acetylsalicylic acid","type":"DRUG"}],"last_update":"2024-02-02","lead_sponsor":"National Cancer Centre, Singapore","official_title":"Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial","overall_status":"UNKNOWN","phases":["PHASE3"],"primary_completion_date":{"date":"2024-06","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Disease-free survival","timeFrame":"5 years"}],"references":[{"citation":"Segelov E, Prenen H, Day D, Macintyre CR, Foo EMJ, Ali R, Wang Q, Wei X, Lopes GL Jr, Ding K, Chen G, Chia JWK, Toh HC; ASCOLT Investigators. Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial. JCO Glob Oncol. 2020 Apr;6:585-588. doi: 10.1200/GO.20.00072. No abstract available.","pmid":"32293940","type":"BACKGROUND"},{"citation":"Day D, Toh HC, Ali R, Foo EMJ, Simes J, Chia JWK, Segelov E; ASCOLT Investigators. Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial. JCO Glob Oncol. 2023 Jun;9:e2300040. doi: 10.1200/GO.23.00040.","pmid":"37364220","type":"BACKGROUND"},{"citation":"Segelov E, Li S, Li I, Mouradov D, Yip S, Day D, Jeffery M, Zielinski R, Nott L, Sun Y, Christie M, Ho GF, Chao TY, Rahman N, Foo E, Chia J, Gebski V, Toh HC, Sieber OM, Simes J. Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis. EBioMedicine. 2026 Aug;130:106389. doi: 10.1016/j.ebiom.2026.106389. Epub 2026 Jul 20.","pmid":"42475879","type":"DERIVED"},{"citation":"Chia JWK, Segelov E, Deng Y, Ho GF, Wang W, Han S, Sharma A, Ding K, Chen G, Jeffery MG, Tham CK, Ahn JB, Nott L, Zielinski R, Chao TY, van Hagen T, Wei PL, Day F, Mehta S, Yau T, Peng J, Hayes TM, Li Y, Gandhi M, Foo EMJ, Rahman N, Rothwell P, Ali R, Simes J, Toh HC. Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2025 Mar;10(3):198-209. doi: 10.1016/S2468-1253(24)00387-X. Epub 2025 Jan 14.","pmid":"39824200","type":"DERIVED"},{"citation":"Ali R, Toh HC, Chia WK; ASCOLT Trial Investigators. The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial. Trials. 2011 Dec 14;12:261. doi: 10.1186/1745-6215-12-261.","pmid":"22168568","type":"DERIVED"}],"start_date":{"date":"2008-12","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers","url":"https://clinicaltrials.gov/study/NCT00565708"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/ascolt-nct00565708"}